Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Scheid

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
British Journal of Haematology|July 23, 2024
Molecular monitoring of MDS: Watch this space!Christof Scheid
Deutsche Medizinische Wochenschrift (1946)|July 5, 2022
Christof Scheid
British Journal of Haematology|April 11, 2023
Refractory multiple myeloma: Count refractory drugs, not lines of treatment!Christof Scheid
The Lancet. Oncology|December 17, 2015
ENDEAVOR to change treatment for multiple myeloma?Christof Scheid
British Journal of Haematology|January 3, 2024
Early detection of multiple myeloma: A first step towards a screening programmeChristof Scheid, Ola Landgren
The Lancet. Haematology|August 24, 2024
Second allogeneic stem-cell transplantation or donor lymphocyte infusion in patients who relapse after transplantation?Marie Robin, Christof Scheid
Deutsche Medizinische Wochenschrift (1946)|June 20, 2020
[Current Recommendations for the First-Line Therapy of Symptomatic Multiple Myeloma]Lukas John, Hartmut Goldschmidt, Christof Scheid
Deutsche Medizinische Wochenschrift (1946)|June 7, 2018
[Infusion of Daratumumab in Combination Therapies - Practical Information for The Outpatient Area]Christof Scheid, Markus Munder, Hans Salwender, et al.
Annals of Hematology|April 28, 2010
Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximabJens Marcus Chemnitz, Jens Uener, Michael Hallek, et al.
European Journal of Haematology|January 6, 2004
Fatal toxic bone marrow failure associated with clopidogrelJens Chemnitz, Dietmar Söhngen, Armin Schulz, et al.
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|July 23, 2024
Molecular monitoring of MDS: Watch this space!Christof Scheid
Deutsche Medizinische Wochenschrift (1946)|July 5, 2022
Christof Scheid
British Journal of Haematology|April 11, 2023
Refractory multiple myeloma: Count refractory drugs, not lines of treatment!Christof Scheid
The Lancet. Oncology|December 17, 2015
ENDEAVOR to change treatment for multiple myeloma?Christof Scheid
British Journal of Haematology|January 3, 2024
Early detection of multiple myeloma: A first step towards a screening programmeChristof Scheid, Ola Landgren
The Lancet. Haematology|August 24, 2024
Second allogeneic stem-cell transplantation or donor lymphocyte infusion in patients who relapse after transplantation?Marie Robin, Christof Scheid
Deutsche Medizinische Wochenschrift (1946)|June 20, 2020
[Current Recommendations for the First-Line Therapy of Symptomatic Multiple Myeloma]Lukas John, Hartmut Goldschmidt, Christof Scheid
Deutsche Medizinische Wochenschrift (1946)|June 7, 2018
[Infusion of Daratumumab in Combination Therapies - Practical Information for The Outpatient Area]Christof Scheid, Markus Munder, Hans Salwender, et al.
Annals of Hematology|April 28, 2010
Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximabJens Marcus Chemnitz, Jens Uener, Michael Hallek, et al.
European Journal of Haematology|January 6, 2004
Fatal toxic bone marrow failure associated with clopidogrelJens Chemnitz, Dietmar Söhngen, Armin Schulz, et al.
Pageof 20